Avalyn Pharma Inc. went public at $18.00 a share
It sold 16,666,667 shares on Nasdaq Global Select Market under the ticker AVLN and raised $300.0 million before costs.
Final prospectus (424B4) filed April 30, 2026
The terms
-
Offered
16,666,667 shares
Checked
Source
“We are offering 16,666,667 shares of our common stock.”
A model read this, and code confirmed the quote appears in the filing. -
Price per share
$18.00
Checked
Source
“The initial public offering price per share is $18.00.”
A model read this, and code confirmed the quote appears in the filing. -
Raised
$300,000,006before fees and costs
Checked
Source and check
Shares × price = 16,666,667 × $18.00 = $300,000,006. They match.
“Initial public offering price | $18.00 | $300,000,006”
A model read this, and code confirmed the quote appears in the filing. -
Bank fee
$21,000,000$1.26 a share, 7.0% of the raise
Checked
Source
“Underwriting discounts and commissions (1) | $1.26 | $21,000,000”
A model read this, and code confirmed the quote appears in the filing. -
Lead banks
Morgan Stanley, Jefferies, Evercore ISI, Guggenheim Securities
From the prospectus
Source
“Morgan Stanley | Jefferies | Evercore ISI | Guggenheim Securities”
A model read this, and code confirmed the quote appears in the filing. -
Trades as
AVLN on Nasdaq Global Select Market
Checked
Source
“Our common stock has been approved for listing on the Nasdaq Global Select Market under the symbol “AVLN.””
A model read this, and code confirmed the quote appears in the filing. -
Extra for the banks
Up to 2,500,000 sharesan option the banks may use
From the prospectus
Source
“We have granted the underwriters the option to purchase up to an additional 2,500,000 shares of common stock from us, at the initial public offering price, less the underwriting discounts and commissions.”
A model read this, and code confirmed the quote appears in the filing. - Final prospectus filed April 30, 2026
Not investment advice.Open the filing on SEC.gov
Who owns the company after the IPO
From the prospectus 16,666,667 of 41,812,047 shares outstanding after the offering (39.9%).
Where Avalyn Pharma Inc. sits among the last 12 months
Each bubble is one IPO. Bigger and higher means more money raised. The scale grows by ten times at each line.
New to these terms? How to read an IPO.